{{ $t("message.ADVERTISEMENT") }}
{{ $t("message.AD_EXPIRE_DATE") }}{{ad01_expire_date}}
{{ $t("message.ADVERTISEMENT") }}
{{ $t("message.AD_EXPIRE_DATE") }}{{ad02_expire_date}}
Art
J-GLOBAL ID:201102256339583824   Reference number:11A0124987

Investigation of optimal anticoagulation strategy for stroke prevention in Japanese patients with atrial fibrillation-The J-RHYTHM Registry study design

心房細動の日本人患者において発作防止のための最適な抗凝固戦略の研究-J-RHYTHM登録研究デザイン
Author (5):
Material:
Volume: 57  Issue:Page: 95-99  Publication year: Jan. 2011
JST Material Number: W2218A  ISSN: 0914-5087  Document type: Article
Article type: 原著論文  Country of issue: United Kingdom (GBR)  Language: ENGLISH (EN)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("テキストリンク | 文献 | EN | PC", "JDreamIII(抄録)", "http://jdream3.com/lp/jglobal/index.html?docNo=11A0124987&from=J-GLOBAL&jstjournalNo=W2218A") }}
JST classification (1):
JST classification
Category name(code) classified by JST.
Drug therapy(=pharmacotherapy)for cardiovascular system diseases 
Reference (15):
  • FUSTER, V. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and Heart Rhythm Society. Circulation. 2006, 114, 700-752
  • OGAWA, S. Guidelines for pharmacotherapy of atrial fibrillation. Circ J. 2008, 72, Suppl. IV, 1581-1638
  • YASAKA, M. Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation. Intern Med. 2001, 40, 1183-1188
  • SHEN, AYJ. Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation. J Am Coll Cardiol. 2007, 50, 309-315
  • JOHNSON, JA. Ethnic differences in cardiovascular drug response. Potential contribution of pharmacogenetics. Circulation. 2008, 118, 1383-1393
more...

Return to Previous Page